$CURR News on impressive endorsement: Nicole Kidman

New Post Public Reply Private Reply Replies (0) Message Board
Lee Adams
96
$CURR News on impressive endorsement: Nicole Kidman Partners With Sera Labs A CURE Pharmaceutical Company As A Strategic Business Partner And Global Brand Ambassador

Sera Labs is a Leading CBD Health, Wellness & Beauty Company
Kidman's partnership is exclusively with Sera Labs Topicals

LOS ANGELES, Dec. 10, 2020 /PRNewswire/ -- The Sera Labs Inc., a wholly owned subsidiary of CURE Pharmaceutical Holdings (OTCQB: CURR) has enlisted Oscar, Golden Globe and Emmy Award-winning Nicole Kidman as the brand's first-ever strategic business partner and global brand ambassador for their topical products. In addition to being the face of the brand, Kidman will play an integral role in the strategic direction of product development and messaging.

"We could not be more excited by Nicole's decision to join our team," says Nancy Duitch, Sera Labs CEO and CURE Pharmaceutical Chief Strategic Officer. "We wanted to work with someone who genuinely cares about growing the business as much as we do. A person just looking to lend their name was never going to work for us. She is savvy, forward thinking and embodies our brand values."

Kidman became a proponent of the benefits of topical CBD when she experimented with it on an ankle injury last summer. She will bring her vast experience of the beauty sector to help Sera Labs boost its multi-channel distribution efforts and sales for its anti-aging skincare line, Seratopical® and topical ultra-hydrating and pain relief body creams and serums. The deal includes nine current Sera Labs topical products with an additional three products set to launch in 2021 where Kidman will be key in development.

"The partnership with Sera Labs was an easy decision for me," states Kidman, Sera Labs Strategic Partner and Global Brand Ambassador. "With my injury last year, I experienced the benefit of CBD wellness products firsthand. I believe these products are a vital solution in health and wellness and Nancy and Sera Labs are a company I believe in. Joining them in this partnership is something I am very excited about!"

Sera Labs was founded in 2018 and is a global leader in the health, wellness, and beauty sectors. CURE Pharmaceutical Holdings which acquired Sera Labs in 2020 is focused on the innovation of pharmaceutical technology, wellness products and drug delivery. "The growth and global interest of our newest acquisition Sera Labs has been tremendous over the past few months," said CURE Pharmaceutical CEO, Rob Davidson. "Nicole will undoubtedly help Sera Labs reach more consumers than ever before and grow our revenue exponentially over the next few years."

Sera Labs can be found online and in national and regional store chains.

For more information visit: www.Seratopical.com and follow us on Instagram at @seratopical, or on Facebook or contact: press@theseralabs.com

About Sera Labs
SeraLabs® is a trusted leader in the health, wellness, and beauty sectors of innovative products with cutting edge technology and superior ingredients such as CBD. Sera Labs creates high quality products that use science-backed, proprietary formulations. Its more than 20 products are sold under the brand names Seratopical™, SeraLabs™, Gordon's Herbals™ and SeraPets™. Sera Labs sells its products at affordable prices, making them easily accessible on a global scale. Strategically positioned in the growth market categories of beauty, health & wellness, and pet care, Sera Labs products are sold in major national drug, grocery chains and mass retailers. The company also sells products under private label to major retailers and multi-level marketers, as well as direct-to-consumer (DTC), via online website orders, including opt-in subscriptions. For more information visit: www.Seratopical.com and follow us on Instagram at @seratopical, or on Facebook or contact: press@theseralabs.com

About CURE Pharmaceutical Holding Corp.
CURE Pharmaceutical® is the pioneering developer of CUREform™, a patented drug delivery platform that offers a number of unique immediate- and controlled-release drug delivery vehicles designed to improve drug efficacy, safety, and patient experience for a wide range of active ingredients.

As a vertically integrated company, CURE's 25,000 square foot, FDA-registered, NSF® and cGMP-certified manufacturing facility enables it to partner with pharmaceutical and wellness companies worldwide for private and white-labeled production. CURE has partnerships in the U.S., China, Mexico, Canada, Israel, and other markets in Europe.

Media Contacts:
Monica M. Jaramillo, LABEL the Agency, mjaramillo@labeltheagency.com, 424.273.8675,
Investor Relations, Kathryn Brown, seralabs@cmwmedia.com, 858.264.6600



Cision View original content:http://www.prnewswire.com/news-releases/nicole-kidman-partners-with-sera-labs-a-cure-pharmaceutical-company-as-a-strategic-business-partner-and-global-brand-ambassador-301190470.html

SOURCE The Sera Labs, Inc.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

USPS Honors 150 Years of the U.S. Coast Guard Academy

Updated Category News Views 7

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Continue Reading
U.S. Green Beret's Mission: Clearing Landmines in Ukraine

Updated Category News Views 3

The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...

Continue Reading
D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 3

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Damp or Dry: The Battle for Healthy Air in Colorado

Updated Category News Views 5

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 4

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 4

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 6

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 5

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Pizza: The Unlikely Symbol of Universal Togetherness

Updated Category News Views 6

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

Continue Reading

Top 5 Most Recently Viewed Articles

Waller Supports Fed's Strategic Interest Rate Adjustment

Updated Category News Views 141

Waller Backs Fed's Rate Adjustment Strategy In a recent conversation about the Federal Reserve's monetary policy, Board of Governors Member Christopher Waller provided insights into the FOMC's choice to cut interest rates by 50 basis points. This announcement drew considerable attention during an interview broadcasted on a well-known financial news channel. These remarks...

Continue Reading
BayCare Welcomes Lynnette A. Clinton as New Chief Information Officer

Updated Category News Views 268

BayCare Health System Welcomes Lynnette A. Clinton Lynnette A. Clinton has made a significant return to BayCare Health System, taking on the key role of Chief Information Officer (CIO). Having previously served as the vice president of applications, Clinton is recognized for her leadership skills and dedication to advancing healthcare technology. Leadership Role and...

Continue Reading
FLSmidth Announces Successful Share Buy-Back Transactions

Updated Category News Views 212

FLSmidth's Strategic Share Buy-Back Program FLSmidth & Co. A/S has embarked on a significant share buy-back initiative aimed at enhancing shareholder value and demonstrating confidence in its operational capabilities. The company, a leading supplier of technology and services to the global mining industry, announced a program that allows for the repurchase of shares up to...

Continue Reading
Patrick Industries Boosts Quarterly Dividend for Investors

Updated Category News Views 121

Patrick Industries Announces Dividend Increase Patrick Industries, Inc. (NASDAQ: PATK) recently revealed an increase in its quarterly cash dividend, a move that reflects the company's lasting commitment to its shareholders and the robustness of its operational model. This decision comes as part of the company's ongoing strategy to deliver rewarding returns to investors....

Continue Reading
Omega Healthcare: Leading the Way in Ambulatory RCM Services

Updated Category News Views 117

Omega Healthcare Celebrates Recognition in RCM Services Omega Healthcare has been honored with the prestigious 2026 Best in KLAS award, distinguishing itself as a top performer in Ambulatory RCM Services. With an outstanding overall performance score of 92.2, this recognition marks a significant milestone for the company, reflecting its commitment to delivering...

Continue Reading